+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Human Insulin Market, By Indication (Type I Diabetes, Type II Diabetes), By Brand (Lantus, Humulin R, Novolin R, Humulin N, Exubera, Afrezza, Novolin N), By Route of Administration, By Type, By Onset Time, By Products, By Region, Forecast & Opportunities, 2025

  • ID: 5022678
  • Report
  • January 2021
  • Region: Global
  • TechSci Research
Global Human Insulin Market Was Valued at USD 26.91 Billion in 2019 is Expected to Grow at a Steady CAGR of 8.01% During the Forecast Period

FEATURED COMPANIES

  • A-S Medication Solutions
  • BioGenomics Ltd
  • Mannkind Corporation
  • Novo Nordisk A/S
  • Remedyrepack Inc.
  • Torrent Pharmaceuticals
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

Global human insulin market was valued at USD 26.91 Billion in 2019 is expected to grow at a steady CAGR of 8.01% during the forecast period.

Growing geriatric population, increasing diabetic patients, rising prevalence of obesity, and increasing demand for human insulin analogs are contributing to the surging demand for human insulin market, globally. Now a days, diabetes is not only restricted to geriatric population, but it is also common among youth. Also, the technological advancements have eradicated human physical activities leading to obesity and diabetes disorders which is directly influencing the growth of the market. Cost effectiveness, reimbursement prices and strict regulatory requirements for approval of insulin can be considered as a major restraining factor for the market as everyone suffering from diabetes might not be able to afford insulin.

The global human insulin market is segmented on the basis of indication, brand, route of administration, type, onset type, products, and region. Based on indication, market can be bifurcated into type I diabetes and type II diabetes. Type I diabetes is likely to hold the largest market share until 2025 as, human insulin is the most important treatment method for the people suffering from type I diabetes. Based on brand, Lantus segment held the dominant market which is one of the major selling products of Sanofi S.A. As of 2019, subcutaneous segment was the leading segment on the basis of route of administration. This is the most common and preferred route of administration as the insulin is absorbed more quickly. Based on regional analysis, North America dominated the human insulin market in 2019 due to large pool of population suffering from diabetes and presence of leading companies in countries like US and Canada.

Leading players in the global human insulin market include Nektar Therapeutics, MannKind Corporation, Novo Nordisk A/S, Torrent Pharmaceuticals, Inc., Eli Lilly and Company, A-S Medication Solutions, RemedyRepack Inc., Sedico Co., Pharmaceutical Company, Sanofi S.A., Gan & Lee Pharmaceuticals, BioGenomics Ltd., Pfizer Inc., PerkinElmer, Merck & Co., Inc, Biocon Limited, Wockhardt Ltd., Ypsomed AG, Becton Dickinson and Company, B. Braun Melsungen AG, Baxter International Inc., among others.

Years considered for this report:
Historical Years: 2015-2018
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2021–2025

Objective of the Study:
  • To analyze and forecast the market size of global human insulin market.
  • To classify and forecast global human insulin market based on indication, brand, route of administration, type, onset type, products and region.
  • To identify drivers and challenges for global human insulin market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global human insulin market.
  • To conduct pricing analysis for global human insulin market.
  • To identify and analyze the profile of leading players operating in global human insulin market.
The analyst performed both primary as well as exhaustive secondary research for this study. Initially, the analyst sourced a list of hospitals/clinics across the globe. Subsequently, the analyst conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the analyst could include the hospitals/clinics which could not be identified due to the limitations of secondary research. The publisher analyzed the hospitals/clinics and presence of all major players across the globe.

The analyst calculated the market size of global human insulin market using a bottom-up approach, wherein data for various End-user segments was recorded and forecast for the future years. The analyst sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by the analyst.

Key Target Audience:
  • Hospitals/clinics, research institutes and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to human insulin
Market Research and Consulting Firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals/clinics, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global human insulin market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Market, By Indication:
  • Type I Diabetes
  • Type II Diabetes
Market, By Brand:
  • Lantus
  • Humulin R
  • Novolin R
  • Humulin N
  • Exubera
  • Afrezza
  • Novolin N
Market, By Route of Administration:
  • Subcutaneous
  • Nasal
  • Intravenous
  • Transdermal
  • Oral
  • Others
Market, By Type:
  • Basal
  • Bolus
  • Pre-mixed
  • Biosimilar
  • Traditional
Market, By Onset Time:
  • Rapid acting
  • Short-acting
  • Intermediate acting
  • Long acting
  • Ultra-long acting
  • Pre-mixed
  • Inhaled
Market, By Products:
  • Insulin Pens
  • Insulin Pumps
  • Infusion System
  • Injection
Market, By Region:
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle east & Africa
Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global human insulin market.

Available Customizations:

With the given market data, the analyst offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information
  • Detailed analysis and profiling of additional market players (up to five).

This report will be delivered within 3 business days and will include the latest impact analysis of COVID-19.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • A-S Medication Solutions
  • BioGenomics Ltd
  • Mannkind Corporation
  • Novo Nordisk A/S
  • Remedyrepack Inc.
  • Torrent Pharmaceuticals
1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Human Insulin Market

4. Executive Summary

5. Voice of Customer

6. Global Human Insulin Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value & Volume
6.2. Market Share & Forecast
6.2.1. By Indication (Type I Diabetes, Type II Diabetes)
6.2.2. By Brand (Lantus, Humulin R, Novolin R, Humulin N, Exubera, Afrezza, Novolin N)
6.2.3. By Route of administration (Subcutaneous, Nasal, Intravenous, Transdermal, Oral and Others)
6.2.4. By Type (Basal, Bolus, Pre-mixed, Biosimilar, Traditional)
6.2.5. By Onset Time (Rapid Acting, Short-Acting, Intermediate Acting, Long Acting, Ultra-long Acting, Pre-Mixed, Inhaled)
6.2.6. By Products (Insulin Pens, Insulin Pumps, Infusion System, Injection)
6.2.7. By Company (2019)
6.2.8. By Region
6.3. Market Attractiveness Index

7. North America Human Insulin Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value & Volume
7.2. Market Share & Forecast
7.2.1. By Indication
7.2.2. By Brand
7.2.3. By Route of Administration
7.2.4. By Type
7.2.5. By Onset Time
7.2.6. By Products
7.2.7. By Country
7.3. Market Attractiveness Index
7.4. North America: Country Analysis
7.4.1. United States Human Insulin Market Outlook
7.4.1.1. Market Size & Forecast
7.4.1.1.1. By Value
7.4.1.2. Market Share & Forecast
7.4.1.2.1. By Indication
7.4.1.2.2. By Brand
7.4.1.2.3. By Route of Administration
7.4.1.2.4. By Type
7.4.1.2.5. By Onset Time
7.4.1.2.6. By Products
7.4.2. Canada Human Insulin Market Outlook
7.4.2.1. Market Size & Forecast
7.4.2.1.1. By Value
7.4.2.2. Market Share & Forecast
7.4.2.2.1. By Indication
7.4.2.2.2. By Brand
7.4.2.2.3. By Route of Administration
7.4.2.2.4. By Type
7.4.2.2.5. By Onset Time
7.4.2.2.6. By Products
7.4.3. Mexico Human Insulin Market Outlook
7.4.3.1. Market Size & Forecast
7.4.3.1.1. By Value
7.4.3.2. Market Share & Forecast
7.4.3.2.1. By Indication
7.4.3.2.2. By Brand
7.4.3.2.3. By Route of Administration
7.4.3.2.4. By Type
7.4.3.2.5. By Onset Time
7.4.3.2.6. By Products

8. Europe Human Insulin Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value & Volume
8.2. Market Share & Forecast
8.2.1. By Indication
8.2.2. By Brand
8.2.3. By Route of Administration
8.2.4. By Type
8.2.5. By Onset Time
8.2.6. By Products
8.2.7. By Country
8.3. Market Attractiveness Index
8.4. Europe: Country Analysis
8.4.1. Germany Human Insulin Market Outlook
8.4.1.1. Market Size & Forecast
8.4.1.1.1. By Value
8.4.1.2. Market Share & Forecast
8.4.1.2.1. By Indication
8.4.1.2.2. By Brand
8.4.1.2.3. By Route of Administration
8.4.1.2.4. By Type
8.4.1.2.5. By Onset Time
8.4.1.2.6. By Products
8.4.2. United Kingdom Human Insulin Market Outlook
8.4.2.1. Market Size & Forecast
8.4.2.1.1. By Value
8.4.2.2. Market Share & Forecast
8.4.2.2.1. By Indication
8.4.2.2.2. By Brand
8.4.2.2.3. By Route of Administration
8.4.2.2.4. By Type
8.4.2.2.5. By Onset Time
8.4.2.2.6. By Products
8.4.3. France Human Insulin Market Outlook
8.4.3.1. Market Size & Forecast
8.4.3.1.1. By Value
8.4.3.2. Market Share & Forecast
8.4.3.2.1. By Indication
8.4.3.2.2. By Brand
8.4.3.2.3. By Route of Administration
8.4.3.2.4. By Type
8.4.3.2.5. By Onset Time
8.4.3.2.6. By Products
8.4.4. Italy Human Insulin Market Outlook
8.4.4.1. Market Size & Forecast
8.4.4.1.1. By Value
8.4.4.2. Market Share & Forecast
8.4.4.2.1. By Indication
8.4.4.2.2. By Brand
8.4.4.2.3. By Route of Administration
8.4.4.2.4. By Type
8.4.4.2.5. By Onset Time
8.4.4.2.6. By Products
8.4.5. Spain Human Insulin Market Outlook
8.4.5.1. Market Size & Forecast
8.4.5.1.1. By Value
8.4.5.2. Market Share & Forecast
8.4.5.2.1. By Indication
8.4.5.2.2. By Brand
8.4.5.2.3. By Route of Administration
8.4.5.2.4. By Type
8.4.5.2.5. By Onset Time
8.4.5.2.6. By Products
8.4.6. Russia Human Insulin Market Outlook
8.4.6.1. Market Size & Forecast
8.4.6.1.1. By Value
8.4.6.2. Market Share & Forecast
8.4.6.2.1. By Indication
8.4.6.2.2. By Brand
8.4.6.2.3. By Route of Administration
8.4.6.2.4. By Type
8.4.6.2.5. By Onset Time
8.4.6.2.6. By Products

9. Asia-Pacific Human Insulin Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value & Volume
9.2. Market Share & Forecast
9.2.1. By Indication
9.2.2. By Brand
9.2.3. By Route of Administration
9.2.4. By Type
9.2.5. By Onset Time
9.2.6. By Products
9.2.7. By Country
9.3. Market Attractiveness Index
9.4. Asia-Pacific: Country Analysis
9.4.1. China Human Insulin Market Outlook
9.4.1.1. Market Size & Forecast
9.4.1.1.1. By Value
9.4.1.2. Market Share & Forecast
9.4.1.2.1. By Indication
9.4.1.2.2. By Brand
9.4.1.2.3. By Route of Administration
9.4.1.2.4. By Type
9.4.1.2.5. By Onset Time
9.4.1.2.6. By Products
9.4.2. India Human Insulin Market Outlook
9.4.2.1. Market Size & Forecast
9.4.2.1.1. By Value
9.4.2.2. Market Share & Forecast
9.4.2.2.1. By Indication
9.4.2.2.2. By Brand
9.4.2.2.3. By Route of Administration
9.4.2.2.4. By Type
9.4.2.2.5. By Onset Time
9.4.2.2.6. By Products
9.4.3. Japan Human Insulin Market Outlook
9.4.3.1. Market Size & Forecast
9.4.3.1.1. By Value
9.4.3.2. Market Share & Forecast
9.4.3.2.1. By Indication
9.4.3.2.2. By Brand
9.4.3.2.3. By Route of Administration
9.4.3.2.4. By Type
9.4.3.2.5. By Onset Time
9.4.3.2.6. By Products
9.4.4. South Korea Human Insulin Market Outlook
9.4.4.1. Market Size & Forecast
9.4.4.1.1. By Value
9.4.4.2. Market Share & Forecast
9.4.4.2.1. By Indication
9.4.4.2.2. By Brand
9.4.4.2.3. By Route of Administration
9.4.4.2.4. By Type
9.4.4.2.5. By Onset Time
9.4.4.2.6. By Products
9.4.5. Australia Human Insulin Market Outlook
9.4.5.1. Market Size & Forecast
9.4.5.1.1. By Value
9.4.5.2. Market Share & Forecast
9.4.5.2.1. By Indication
9.4.5.2.2. By Brand
9.4.5.2.3. By Route of Administration
9.4.5.2.4. By Type
9.4.5.2.5. By Onset Time
9.4.5.2.6. By Products
9.4.6. Singapore Human Insulin Market Outlook
9.4.6.1. Market Size & Forecast
9.4.6.1.1. By Value
9.4.6.2. Market Share & Forecast
9.4.6.2.1. By Indication
9.4.6.2.2. By Brand
9.4.6.2.3. By Route of Administration
9.4.6.2.4. By Type
9.4.6.2.5. By Onset Time
9.4.6.2.6. By Products

10. South America Human Insulin Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value & Volume
10.2. Market Share & Forecast
10.2.1. By Indication
10.2.2. By Brand
10.2.3. By Route of Administration
10.2.4. By Type
10.2.5. By Onset Time
10.2.6. By Products
10.2.7. By Country
10.3. Market Attractiveness Index
10.4. South America: Country Analysis
10.4.1. Brazil Human Insulin Market Outlook
10.4.1.1. Market Size & Forecast
10.4.1.1.1. By Value
10.4.1.2. Market Share & Forecast
10.4.1.2.1. By Indication
10.4.1.2.2. By Brand
10.4.1.2.3. By Route of Administration
10.4.1.2.4. By Type
10.4.1.2.5. By Onset Time
10.4.1.2.6. By Products
10.4.2. Argentina Human Insulin Market Outlook
10.4.2.1. Market Size & Forecast
10.4.2.1.1. By Value
10.4.2.2. Market Share & Forecast
10.4.2.2.1. By Indication
10.4.2.2.2. By Brand
10.4.2.2.3. By Route of Administration
10.4.2.2.4. By Type
10.4.2.2.5. By Onset Time
10.4.2.2.6. By Products
10.4.3. Colombia Human Insulin Market Outlook
10.4.3.1. Market Size & Forecast
10.4.3.1.1. By Value
10.4.3.2. Market Share & Forecast
10.4.3.2.1. By Indication
10.4.3.2.2. By Brand
10.4.3.2.3. By Route of Administration
10.4.3.2.4. By Type
10.4.3.2.5. By Onset Time
10.4.3.2.6. By Products

11. Middle East and Africa Human Insulin Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value & Volume
11.2. Market Share & Forecast
11.2.1. By Indication
11.2.2. By Brand
11.2.3. By Route of Administration
11.2.4. By Type
11.2.5. By Onset Time
11.2.6. By Products
11.2.7. By Country
11.3. Market Attractiveness Index
11.4. MEA: Country Analysis
11.4.1. Saudi Arabia Human Insulin Market Outlook
11.4.1.1. Market Size & Forecast
11.4.1.1.1. By Value
11.4.1.2. Market Share & Forecast
11.4.1.2.1. By Indication
11.4.1.2.2. By Brand
11.4.1.2.3. By Route of Administration
11.4.1.2.4. By Type
11.4.1.2.5. By Onset Time
11.4.1.2.6. By Products
11.4.2. South Africa Human Insulin Market Outlook
11.4.2.1. Market Size & Forecast
11.4.2.1.1. By Value
11.4.2.2. Market Share & Forecast
11.4.2.2.1. By Indication
11.4.2.2.2. By Brand
11.4.2.2.3. By Route of Administration
11.4.2.2.4. By Type
11.4.2.2.5. By Onset Time
11.4.2.2.6. By Products
11.4.3. UAE Human Insulin Market Outlook
11.4.3.1. Market Size & Forecast
11.4.3.1.1. By Value
11.4.3.2. Market Share & Forecast
11.4.3.2.1. By Indication
11.4.3.2.2. By Brand
11.4.3.2.3. By Route of Administration
11.4.3.2.4. By Type
11.4.3.2.5. By Onset Time
11.4.3.2.6. By Products

12. Market Dynamics
12.1. Drivers
12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape
14.1. Competition Outlook
14.2. Players Profiled (Leading Companies)
14.2.1. Novo Nordisk A/S
14.2.2. Sanofi S.A.
14.2.3. Eli Lilly and Company
14.2.4. Biocon Limited
14.2.5. Wockhardt Ltd
14.2.6. Nektar Therapeutics
14.2.7. Mannkind Corporation
14.2.8. A-S Medication Solutions
14.2.9. Remedyrepack Inc.
14.2.10. Torrent Pharmaceuticals
14.2.11. Sedico Co.
14.2.12. Gan & Lee Pharmaceuticals
14.2.13. BioGenomics Ltd
14.2.14. Ypsomed AG
14.2.15. Becton, Dickinson and Company
14.2.16. B. Braun Melsungen AG
14.2.17. Baxter International Inc.
14.2.18. Merck & Co., Inc
14.2.19. PerkinElmer
14.2.20. Pfizer Inc.

15. Strategic Recommendations

16. About Us & Disclaimer

List of Figures
Figure 1: Global Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
Figure 2: Global Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 3: Global Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 4: Global Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 5: Global Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 6: Global Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 7: Global Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 8: Global Human Insulin Market Share, By Company, By Value, 2019
Figure 9: Global Human Insulin Market Share, By Region, By Value, 2015-2025F
Figure 10: Global Human Insulin Market Share, By Region, By Value, 2015-2025F
Figure 11: Global Human Insulin Market Map, By Brand, Market Size (USD Billion) & Growth Rate (%)
Figure 12: Global Human Insulin Market Map, By Onset Time, Market Size (USD Billion) & Growth Rate (%)
Figure 13: Global Human Insulin Market Map, By Products, Market Size (USD Billion) & Growth Rate (%)
Figure 14: Global Human Insulin Market Map, By Region, Market Size (USD Billion) & Growth Rate (%)
Figure 15: North America Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
Figure 16: North America Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 17: North America Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 18: North America Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 19: North America Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 20: North America Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 21: North America Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 22: North America Human Insulin Market Share, By Country, By Value, 2015-2025F
Figure 23: North America Human Insulin Market Map, By Brand, Market Size (USD Billion) & Growth Rate (%)
Figure 24: United States Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
Figure 25: Total Number of Diabetes patients in United States, By Value (Millions), 2019, 2030, 2045
Figure 26: United States Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 27: United States Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 28: United States Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 29: United States Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 30: United States Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 31: United States Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 32: Canada Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
Figure 33: Total Number of Diabetes patients in Canada, By Value (1000’s), 2010, 2019, 2030, 2045
Figure 34: Canada Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 35: Canada Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 36: Canada Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 37: Canada Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 38: Canada Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 39: Canada Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 40: Mexico Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
Figure 41: Total Number of Diabetes patients in Mexico, By Value (Millions), 2019, 2030, 2045
Figure 42: Mexico Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 43: Mexico Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 44: Mexico Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 45: Mexico Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 46: Mexico Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 47: Mexico Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 48: Europe Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
Figure 49: Europe Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 50: Europe Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 51: Europe Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 52: Europe Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 53: Europe Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 54: Europe Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 55: Europe Human Insulin Market Share, By Country, By Value, 2015-2025F
Figure 56: Europe Human Insulin Market Map, By Brand, Market Size (USD Billion) & Growth Rate (%)
Figure 57: Germany Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
Figure 58: Germany undiagnosed and diagnosed diabetes cases, 2019
Figure 59: Germany Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 60: Germany Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 61: Germany Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 62: Germany Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 63: Germany Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 64: Germany Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 65: United Kingdom Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
Figure 66: Different types of diabetes in United Kingdom, 2019
Figure 67: United Kingdom Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 68: United Kingdom Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 69: United Kingdom Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 70: United Kingdom Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 71: United Kingdom Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 72: United Kingdom Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 73: France Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
Figure 74: France Healthcare Spending, By Value (USD Per Capita), 2015-2019
Figure 75: France Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 76: France Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 77: France Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 78: France Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 79: France Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 80: France Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 81: Italy Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
Figure 82: Total Number of Diabetes patients in Italy, By Value (1000’s), 2010, 2019, 2030, 2045
Figure 83: Italy Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 84: Italy Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 85: Italy Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 86: Italy Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 87: Italy Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 88: Italy Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 89: Spain Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
Figure 90: Total Number of Diabetes patients in Spain, By Value (1000’s), 2010, 2019, 2030, 2045
Figure 91: Spain Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 92: Spain Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 93: Spain Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 94: Spain Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 95: Spain Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 96: Spain Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 97: Russia Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
Figure 98: Total Number of Diabetes patients in Russia, By Value (1000’s), 2010, 2019, 2030, 2045
Figure 99: Russia Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 100: Russia Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 101: Russia Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 102: Russia Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 103: Russia Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 104: Russia Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 105: Asia-Pacific Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
Figure 106: Asia-Pacific Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 107: Asia-Pacific Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 108: Asia-Pacific Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 109: Asia-Pacific Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 110: Asia-Pacific Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 111: Asia-Pacific Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 112: Asia-Pacific Human Insulin Market Share, By Country, By Value, 2015-2025F
Figure 113: Asia-Pacific Human Insulin Market Map, By Brand, Market Size (USD Billion) & Growth Rate (%)
Figure 114: China Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
Figure 115: Total Number of Diabetes patients in China, By Value (Millions), 2019, 2030, 2045
Figure 116: China Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 117: China Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 118: China Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 119: China Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 120: China Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 121: China Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 122: India Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
Figure 123: Total Number of Diabetes patients in India, By Value (Millions), 2019, 2030, 2045
Figure 124: India Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 125: India Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 126: India Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 127: India Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 128: India Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 129: India Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 130: Japan Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
Figure 131: Japan Total Health Expenditure as a share of GDP, 2015 - 2019
Figure 132: Japan Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 133: Japan Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 134: Japan Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 135: Japan Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 136: Japan Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 137: Japan Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 138: South Korea Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
Figure 139: Total Number of Diabetes patients in South Korea, By Value (1000’s), 2010, 2019, 2030, 2045
Figure 140: South Korea Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 141: South Korea Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 142: South Korea Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 143: South Korea Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 144: South Korea Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 145: South Korea Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 146: Australia Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
Figure 147: Total Number of Diabetes patients in Australia, By Value (1000’s), 2010, 2019, 2030, 2045
Figure 148: Australia Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 149: Australia Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 150: Australia Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 151: Australia Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 152: Australia Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 153: Australia Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 154: Singapore Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
Figure 155: Total Number of Diabetes patients in Singapore, By Value (1000’s), 2010, 2019, 2030, 2045
Figure 156: Singapore Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 157: Singapore Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 158: Singapore Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 159: Singapore Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 160: Singapore Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 161: Singapore Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 162: South America Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
Figure 163: South America Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 164: South America Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 165: South America Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 166: South America Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 167: South America Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 168: South America Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 169: South America Human Insulin Market Share, By Country, By Value, 2015-2025F
Figure 170: South America Human Insulin Market Map, By Brand, Market Size (USD Billion) & Growth Rate (%)
Figure 171: Brazil Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
Figure 172: Total Number of Diabetes patients in Brazil, By Value (Millions), 2019, 2030, 2045
Figure 173: Brazil Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 174: Brazil Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 175: Brazil Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 176: Brazil Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 177: Brazil Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 178: Brazil Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 179: Argentina Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
Figure 180: Argentina Health Expenditure (% of GDP), 2015-2019
Figure 181: Argentina Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 182: Argentina Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 183: Argentina Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 184: Argentina Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 185: Argentina Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 186: Argentina Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 187: Colombia Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
Figure 188: Total Number of Diabetes patients in Colombia, By Value (1000’s), 2010, 2019, 2030, 2045
Figure 189: Colombia Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 190: Colombia Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 191: Colombia Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 192: Colombia Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 193: Colombia Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 194: Colombia Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 195: Middle East and Africa Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
Figure 196: Middle East and Africa Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 197: Middle East and Africa Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 198: Middle East and Africa Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 199: Middle East and Africa Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 200: Middle East and Africa Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 201: Middle East and Africa Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 202: Middle East and Africa Human Insulin Market Share, By Country, By Value, 2015-2025F
Figure 203: Middle East & Africa Human Insulin Market Map, By Brand, Market Size (USD Billion) & Growth Rate (%)
Figure 204: Saudi Arabia Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
Figure 205: Total Number of Diabetes patients in Saudi Arabia, By Value (1000’s), 2010, 2019, 2030, 2045
Figure 206: Saudi Arabia Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 207: Saudi Arabia Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 208: Saudi Arabia Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 209: Saudi Arabia Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 210: Saudi Arabia Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 211: Saudi Arabia Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 212: South Africa Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
Figure 213: Total Number of Diabetes patients in South Africa, By Value (1000’s), 2010, 2019, 2030, 2045
Figure 214: South Africa Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 215: South Africa Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 216: South Africa Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 217: South Africa Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 218: South Africa Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 219: South Africa Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 220: UAE Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
Figure 221: UAE Health Expenditure (% of GDP), 2015-2019
Figure 222: UAE Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 223: UAE Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 224: UAE Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 225: UAE Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 226: UAE Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 227: UAE Human Insulin Market Share, By Products, By Value, 2015-2025F
Note: Product cover images may vary from those shown
  • Novo Nordisk A/S
  • Sanofi S.A.
  • Eli Lilly and Company
  • Biocon Limited
  • Wockhardt Ltd
  • Nektar Therapeutics
  • Mannkind Corporation
  • A-S Medication Solutions
  • Remedyrepack Inc.
  • Torrent Pharmaceuticals
  • Sedico Co.
  • Gan & Lee Pharmaceuticals
  • BioGenomics Ltd
  • Ypsomed AG
  • Becton, Dickinson and Company
  • B. Braun Melsungen AG
  • Baxter International Inc.,
  • Merck & Co., Inc
  • PerkinElmer
  • Pfizer Inc.
Note: Product cover images may vary from those shown
Adroll
adroll